I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 12 studies | 33% ± 13% | |
| epithelial cell of proximal tubule | 6 studies | 47% ± 20% | |
| epithelial cell | 4 studies | 23% ± 4% | |
| GABAergic neuron | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 12 studies | 33% ± 13% | |
| epithelial cell of proximal tubule | 6 studies | 47% ± 20% | |
| epithelial cell | 4 studies | 23% ± 4% | |
| GABAergic neuron | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| kidney | 4 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 95% | 1311.09 | 2505 / 2642 | 99% | 36.94 | 695 / 705 |
| thymus | 100% | 1843.11 | 653 / 653 | 91% | 44.80 | 551 / 605 |
| prostate | 95% | 892.81 | 233 / 245 | 87% | 12.67 | 439 / 502 |
| kidney | 94% | 4556.09 | 84 / 89 | 81% | 67.84 | 733 / 901 |
| ovary | 100% | 3126.20 | 180 / 180 | 75% | 15.52 | 322 / 430 |
| adrenal gland | 100% | 21073.67 | 258 / 258 | 57% | 21.39 | 130 / 230 |
| uterus | 100% | 1828.49 | 170 / 170 | 47% | 8.40 | 215 / 459 |
| esophagus | 53% | 715.24 | 764 / 1445 | 50% | 9.48 | 91 / 183 |
| spleen | 100% | 2882.40 | 241 / 241 | 0% | 0 | 0 / 0 |
| intestine | 41% | 535.36 | 395 / 966 | 48% | 6.10 | 251 / 527 |
| bladder | 52% | 232.67 | 11 / 21 | 34% | 4.92 | 169 / 504 |
| blood vessel | 83% | 568.00 | 1112 / 1335 | 0% | 0 | 0 / 0 |
| lung | 22% | 75.52 | 130 / 578 | 54% | 15.23 | 629 / 1155 |
| muscle | 64% | 459.09 | 517 / 803 | 0% | 0 | 0 / 0 |
| breast | 40% | 202.30 | 184 / 459 | 23% | 2.40 | 261 / 1118 |
| pancreas | 30% | 92.43 | 97 / 328 | 25% | 3.49 | 45 / 178 |
| stomach | 21% | 80.88 | 74 / 359 | 32% | 3.93 | 91 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 49% | 7.59 | 22 / 45 |
| heart | 41% | 171.93 | 352 / 861 | 0% | 0 | 0 / 0 |
| adipose | 27% | 101.18 | 324 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 1.84 | 6 / 29 |
| liver | 1% | 3.11 | 3 / 226 | 17% | 4.14 | 70 / 406 |
| peripheral blood | 15% | 85.65 | 141 / 929 | 0% | 0 | 0 / 0 |
| skin | 5% | 17.70 | 83 / 1809 | 3% | 0.56 | 13 / 472 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0046415 | Biological process | urate metabolic process |
| GO_0015881 | Biological process | creatine transmembrane transport |
| GO_0015718 | Biological process | monocarboxylic acid transport |
| GO_1902603 | Biological process | carnitine transmembrane transport |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0015293 | Molecular function | symporter activity |
| GO_0005308 | Molecular function | creatine transmembrane transporter activity |
| GO_0015226 | Molecular function | carnitine transmembrane transporter activity |
| GO_0008028 | Molecular function | monocarboxylic acid transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC16A9 |
| Protein name | Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9) |
| Synonyms | C10orf36 MCT9 |
| Description | FUNCTION: Extracellular pH-and Na(+)-sensitive low-affinity creatine transporter . Functions also as a pH-independent carnitine efflux transporter . . |
| Accessions | ENST00000395348.8 ENST00000395347.1 Q7RTY1 |
